Description

This research service provides an indepth analysis of factors affecting the growth of the U.S. opioid pain management market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by duration of action: long-acting opioids and short-acting opioids. Major market challlenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the opioid pain management pipeline by phase.